https://trials.hemophiliafed.org/trials/CSL654_3004
Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects...
This study will investigate the pharmacokinetics (PK), efficacy, and safety of rIX-FP for the routine prophylaxis of bleeding episodes in male Chinese...
recombinant fusion proteincoagulation factor ixlinkingalbuminrix
https://www.newswire.ca/news-releases/csl-behring-submits-biologics-license-application-for-fda-approval-of-recombinant-fusion-protein-linking-coagulation-factor-ix-with-recombinant-albumin-rix-fp-for-hemophilia-b-patients-522291561.html
CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein...
/PRNewswire/ -- CSL Behring announced today it has submitted a biologics license application (BLA) to the United States Food and Drug Administration (FDA)...
biologics license applicationrecombinant fusion proteincsl behringfda approvalsubmits
https://www.techtransfer.nih.gov/patent/e-135-1989-0-ch-03
RECOMBINANT ANTIBODY - TOXIN FUSION PROTEIN | Technology Transfer
fusion proteintechnology transferrecombinantantibodytoxin